Indian Inhaler Market Size, Share and forecast to 2025

Posted by OMR Global on February 19th, 2020

Indian inhaler market is anticipated to grow at a substantial rate of 7.4% during the forecast period. Major factors that augments the growth of the market include large population base susceptible to asthma and COPD, rising awareness about treatment for asthma and COPD, and significant presence of market players in the country. The Indian inhaler market is segmented on the basis of device, type, application, and end-user. On the basis of device, the market is sub-segmented into metered dosed inhaler, dry powdered inhaler, and nebulizer. The dry powder inhaler is estimated to have largest market share in the Indian inhaler market due to providing easy inhalation solution. Based on the type, preventive, reliever, and long acting bronchodilators inhaler are analyzed. Moreover, on the basis of application, the market has been classified into asthma and COPD diseases. In addition, based on the end-user, homecare and hospitals and clinics have been analyzed.  

Request a Free Sample of our Report on Indian Inhaler Markethttps://www.omrglobal.com/request-sample/indian-inhaler-market 

Cipla is one of the major companies working in the inhaler market. The company offers products in the field of asthma, COPD, Allergic Rhinitis (AR), Pulmonary Arterial Hypertension (PAH), lung cancer and Idiopathic Pulmonary Fibrosis (IPF). In May 2018, the company established a partnership with MannKind for marketing and distributing Afrezza. It is the only US FDA approved inhaled insulin available for patients suffering from diabetes. In addition, the company in February 2018, has entered into a partnership with Roche Pharma India for healthcare improvement and increasing access of life-changing medicines in India. 

A full Report of Indian Inhaler Marketis Available at: https://www.omrglobal.com/industry-reports/indian-inhaler-market 

The Report covers: 

•          Comprehensive research methodology of the Indian inhaler market.
•          This report also includes a detailed and extensive market overview with key analyst insights.
•          An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
•          Analysis of regional regulations and other government policies impacting the Indian inhaler market.
•          Insights about market determinants which are stimulating the Indian inhaler market.
•          Detailed and extensive market segments with regional distribution of forecasted revenues.
•          Extensive profiles and recent developments of market players. 

Indian Inhaler Market Segmentation 

By Device  

•          Metered Dose Inhaler
•          Dry Powder Inhaler
•          Nebulizer  

By Type 

•          Preventive Inhaler
•          Reliever Inhaler
•          Long Acting Bronchodilators Inhaler  

By Application 

•          Asthma 
•          Chronic Obstructive Pulmonary Disease (COPD)
•          Indian Inhaler Market by End-User
•          Homecare
•          Hospitals and Clinics 

Company Profiles 

•          3M Co.
•          Acorda Therapeutics, Inc.
•          Adamis Pharmaceuticals Corp.
•          Adherium Ltd.
•          Aradigm Corp.
•          AstraZeneca PLC
•          Beximo Pharmaceuticals Ltd.
•          Boehringer Ingelheim International GmbH 
•          Cipla Ltd.
•          GlaxoSmithKline PLC
•          Koninklijke Philips N.V.
•          MidasCare Pharmaceutical Pvt. Ltd.
•          Novartis AG
•          Omron Healthcare Inc.
•          Sunovion Pharmaceuticals
•          Teva Pharmaceuticals Industries Ltd. 

About Orion Market Research 

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. 

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no: +1 646-755-7667, +91 780-304-0404